medical education

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part One

Now more than ever, pharmaceutical companies’ relationships with physician thought leaders, also known as key opinion leaders (KOLs), are under intense scrutiny. Industry ethicists and watchdogs alike have speculated on the objectivity of medical education presentations and other aspects of KOL involvement during the marketing of new drug therapies. However, the truth is that physician …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part One Read More »

The Numbers Don't Lie: The Global Impact of Thought Leader Select

Since 2005, Thought Leader Select has profiled over 4800 key opinion leaders and over 300 centers of excellence in the field of healthcare. The scope of our 72 completed research projects spans four continents—North America, Europe, Africa, and Asia. We have covered thought leaders in 12 therapeutic areas and over 33 disease states for the …

The Numbers Don't Lie: The Global Impact of Thought Leader Select Read More »